You might be eligible for compensation if you took the drug Uloric (febuxostat) to manage your gout and suffered severe cardiovascular problems or stroke.
Reach out now
The Time to File Your Claim is LIMITED
You've suffered enough. Now it's time to make them answer for it.
We're ready to pursue justice to the bitter end; contact us to speak to an attorney for free.
Request a Free Consultation Call Now 866-838-5290
Serious cardiovascular harm linked to gout drug, Uloric
Altman-Nussbaum-Shunnarah Trial Attorneyss are standing by to help you no matter where you live. Serving all 50 states, we’ve recovered over $500mil for our clients nationwide. After reviewing the results from a safety clinical trial, The FDA has concluded there is an increased risk of death and heart problems when taking Uloric (febuxostat) to treat gout compared to another competitor, allopurinol. Uloric was FDA-approved in 2009 to lower levels of uric acid buildup in the blood, which can lead to gout. As of 2019, Uloric has a Boxed Warning, the most significant warning for complications administered by the FDA.
In a trial of more than 6,000 patients, the primary outcome of taking Uloric included:
- Heart-related death
- Non-deadly heart attack
- Non-deadly stroke
- Inadequate blood supply
Patients with a history of heart problems or stroke are at an increased risk taking Uloric.
Seek immediate medical attention if you experience:
- Dizziness
- Shortness of breath
- Chest pain
- Trouble talking
- Severe headache
- Rapid, irregular heartbeat
- Numbness or weakness on one side of the body
If you or a loved one has experienced a cardiovascular event from taking Uloric, contact us today. We’ll determine if you have a case and work hard to get you the compensation you deserve. Call Altman-Nussbaum-Shunnarah Personal Injury Attorneys today at 1-800-229-7989.